CPT code 21550 denotes a diagnostic surgical excision of a small portion of soft tissue from the neck or chest, commonly performed to obtain tissue for histologic analysis when malignancy or infection is suspected. Nationally, this code represents a frequently used surgical biopsy procedure that supports definitive diagnosis and subsequent treatment planning in oncology and infectious disease evaluation.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on clinical context, typical sites of service, and the operational considerations that drive billing and utilization for this procedure. The publication outlines benchmark elements and policy-relevant details: coding definition and clinical indications, common care settings, and how payers typically categorize such procedures for coverage and site-of-service determination. Where payer- or policy-specific data are not provided, the text will note that data are not available in the input.

This article is intended for national audiences of clinicians, billing professionals, and policy analysts seeking a clear summary of CPT code 21550, its clinical role, and the kinds of administrative and utilization topics that commonly accompany surgical soft-tissue biopsy procedures.